Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK: The Authors?? Reply

Saved in:
Bibliographic Details
Published in:PharmacoEconomics 2005, Vol.23 (7), p.743-745
Main Authors: Moore, Andrew, Phillips, Ceri, Hunsche, Elke, Pellissier, James, Crespi, Simone
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-crossref_primary_10_2165_00019053_200523070_000093
container_end_page 745
container_issue 7
container_start_page 743
container_title PharmacoEconomics
container_volume 23
creator Moore, Andrew
Phillips, Ceri
Hunsche, Elke
Pellissier, James
Crespi, Simone
description
doi_str_mv 10.2165/00019053-200523070-00009
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_2165_00019053_200523070_00009</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2165_00019053_200523070_00009</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_2165_00019053_200523070_000093</originalsourceid><addsrcrecordid>eNqlj0FOwzAQRb0AiUK5w1wgME6UhCwrCAIhtYi2a8u4E8UosZE9ieAOHJoUQS7AajT_683oCQESr1JZ5NeIKCvMsyRFzNMMS0ymCKsTsZByWsqiwjNxHuPblBZZmS7EV2288701UI-6GzRb78A3ULMP1vgP-wojhThEWHuXbKkjw3YkWG9Xj3cRrANuCXaBNPfk-IhuIpPXgdtg2UbQ7gAvLQ29Zm8PsJqL5-nZhMxH9k9LcdroLtLl77wQN_f17vYhMcHHGKhR78H2OnwqieporP6M1Wysfoyzf6DfzuVjmg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK: The Authors?? Reply</title><source>Springer Nature</source><creator>Moore, Andrew ; Phillips, Ceri ; Hunsche, Elke ; Pellissier, James ; Crespi, Simone</creator><creatorcontrib>Moore, Andrew ; Phillips, Ceri ; Hunsche, Elke ; Pellissier, James ; Crespi, Simone</creatorcontrib><identifier>ISSN: 1170-7690</identifier><identifier>DOI: 10.2165/00019053-200523070-00009</identifier><language>eng</language><ispartof>PharmacoEconomics, 2005, Vol.23 (7), p.743-745</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_2165_00019053_200523070_000093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Moore, Andrew</creatorcontrib><creatorcontrib>Phillips, Ceri</creatorcontrib><creatorcontrib>Hunsche, Elke</creatorcontrib><creatorcontrib>Pellissier, James</creatorcontrib><creatorcontrib>Crespi, Simone</creatorcontrib><title>Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK: The Authors?? Reply</title><title>PharmacoEconomics</title><issn>1170-7690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqlj0FOwzAQRb0AiUK5w1wgME6UhCwrCAIhtYi2a8u4E8UosZE9ieAOHJoUQS7AajT_683oCQESr1JZ5NeIKCvMsyRFzNMMS0ymCKsTsZByWsqiwjNxHuPblBZZmS7EV2288701UI-6GzRb78A3ULMP1vgP-wojhThEWHuXbKkjw3YkWG9Xj3cRrANuCXaBNPfk-IhuIpPXgdtg2UbQ7gAvLQ29Zm8PsJqL5-nZhMxH9k9LcdroLtLl77wQN_f17vYhMcHHGKhR78H2OnwqieporP6M1Wysfoyzf6DfzuVjmg</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>Moore, Andrew</creator><creator>Phillips, Ceri</creator><creator>Hunsche, Elke</creator><creator>Pellissier, James</creator><creator>Crespi, Simone</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2005</creationdate><title>Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK</title><author>Moore, Andrew ; Phillips, Ceri ; Hunsche, Elke ; Pellissier, James ; Crespi, Simone</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_2165_00019053_200523070_000093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Andrew</creatorcontrib><creatorcontrib>Phillips, Ceri</creatorcontrib><creatorcontrib>Hunsche, Elke</creatorcontrib><creatorcontrib>Pellissier, James</creatorcontrib><creatorcontrib>Crespi, Simone</creatorcontrib><collection>CrossRef</collection><jtitle>PharmacoEconomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Andrew</au><au>Phillips, Ceri</au><au>Hunsche, Elke</au><au>Pellissier, James</au><au>Crespi, Simone</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK: The Authors?? Reply</atitle><jtitle>PharmacoEconomics</jtitle><date>2005</date><risdate>2005</risdate><volume>23</volume><issue>7</issue><spage>743</spage><epage>745</epage><pages>743-745</pages><issn>1170-7690</issn><doi>10.2165/00019053-200523070-00009</doi></addata></record>
fulltext fulltext
identifier ISSN: 1170-7690
ispartof PharmacoEconomics, 2005, Vol.23 (7), p.743-745
issn 1170-7690
language eng
recordid cdi_crossref_primary_10_2165_00019053_200523070_00009
source Springer Nature
title Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK: The Authors?? Reply
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T18%3A13%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Economic%20Evaluation%20of%20Etoricoxib%20versus%20Non-Selective%20NSAIDs%20in%20the%20Treatment%20of%20Osteoarthritis%20and%20Rheumatoid%20Arthritis%20Patients%20in%20the%20UK:%20The%20Authors??%20Reply&rft.jtitle=PharmacoEconomics&rft.au=Moore,%20Andrew&rft.date=2005&rft.volume=23&rft.issue=7&rft.spage=743&rft.epage=745&rft.pages=743-745&rft.issn=1170-7690&rft_id=info:doi/10.2165/00019053-200523070-00009&rft_dat=%3Ccrossref%3E10_2165_00019053_200523070_00009%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-crossref_primary_10_2165_00019053_200523070_000093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true